Late additionBuy-out
SHS Capital acquires Basic Pharma
SourcingClub was not involved in this transaction.
SHS Capital acquires a majority stake in Basic Pharma, a Dutch developer and contract manufacturer of nasal sprays. The investment serves as a succession solution for the founder, who reinvests.
In context
In July 2026 it is the 2nd of 5 deals in Healthcare on the Deal-Radar.
Deal-Radar editorial team · responsible: Nick Herbig
late addition, source dated 14 Jul 2026: shs-capital.eu
Who was involved.
- Buyer
- SHS Capital
- Target
- Basic Pharma, Geleen
- Seller
- Gründer
- Type
- Buy-out
- Sector
- Healthcare & Medtech
- Country
Netherlands
- Source dated
- 14/07/2026
- Source
- shs-capital.eu
Deal-Radar no. 47-181 · added in Week 47/2026, first reported on 14/07/2026 · publicly reported, no guarantee · SourcingClub was not involved in this transaction. Report an error · Sources and limits
We report publicly announced information and link the source; we accept no liability for its accuracy. No offer and no investment, legal or tax advice. The operators of linked pages are responsible for their content. We correct errors as soon as we learn of them. The context is based only on deals recorded in the Deal-Radar and is not complete.
Valuation in this industry.
5.9 to 10.0times EBITDA
- 5.9x to 7.6xRevenue under €5m
- 7.0x to 9.0x€5m to €50m
- 8.2x to 10.0xover €50m
Market range for Healthcare & Medical Technology, not the price of this deal. Data basis: DUB KMU-Multiples, Q3/2026; preparation: SourcingClub.
Multiples by size class for Healthcare & Medical Technology 62 deals in this industry on the radar
July 2026 on the Deal-Radar.
8 of 28 deals were of the type Buy-out.
- Buy-out8
- Secondary5
- Minority stake4
- Strategic4
- Add-on3
- Carve-out2
- Succession1
- Funding round1
New deals every day. By email on Mondays.
All deals of the previous week in one email, with source and adviser.



